{"name":"Paion UK Ltd.","slug":"paion-uk-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"D. Midazolam","genericName":"D. Midazolam","slug":"d-midazolam","indication":"Anesthesia","status":"phase_2"},{"name":"B. CNS 7056","genericName":"B. CNS 7056","slug":"b-cns-7056","indication":"Other","status":"phase_2"},{"name":"C. CNS 7056","genericName":"C. CNS 7056","slug":"c-cns-7056","indication":"Other","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Morphine 6-glucuronide","genericName":"Morphine 6-glucuronide","slug":"morphine-6-glucuronide","indication":"Acute and chronic pain management","status":"phase_3"},{"name":"A. CNS 7056","genericName":"A. CNS 7056","slug":"a-cns-7056","indication":"Treatment of acute pain","status":"phase_2"},{"name":"CNS 7056","genericName":"CNS 7056","slug":"cns-7056","indication":"Chronic pain","status":"phase_2"}]}],"pipeline":[{"name":"D. Midazolam","genericName":"D. Midazolam","slug":"d-midazolam","phase":"phase_2","mechanism":"GABA_A receptor agonist","indications":["Anesthesia","Sedation"],"catalyst":""},{"name":"Morphine 6-glucuronide","genericName":"Morphine 6-glucuronide","slug":"morphine-6-glucuronide","phase":"phase_3","mechanism":"Morphine 6-glucuronide is an active metabolite of morphine that binds to opioid receptors in the central nervous system to produce analgesia and other opioid effects.","indications":["Acute and chronic pain management","Postoperative pain"],"catalyst":""},{"name":"A. CNS 7056","genericName":"A. CNS 7056","slug":"a-cns-7056","phase":"phase_2","mechanism":"CNS 7056 is a kappa opioid receptor antagonist.","indications":["Treatment of acute pain"],"catalyst":""},{"name":"B. CNS 7056","genericName":"B. CNS 7056","slug":"b-cns-7056","phase":"phase_2","mechanism":"B. CNS 7056 is an investigational drug with a mechanism that is not fully disclosed publicly.","indications":[],"catalyst":""},{"name":"C. CNS 7056","genericName":"C. CNS 7056","slug":"c-cns-7056","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CNS 7056","genericName":"CNS 7056","slug":"cns-7056","phase":"phase_2","mechanism":"CNS 7056 is a kappa opioid receptor antagonist.","indications":["Chronic pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2019-03-04","type":"pipeline","source":"openPR.com","summary":"General Anesthesia Drugs Market Share Forecast To Witness - openPR.com","headline":"General Anesthesia Drugs Market Share Forecast To Witness","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":5,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}